FL CARES: Cancer Drug Property Dataset

Brand Name:
Code(s): TAS-120
Approved:
Kinase Class: RY
Inhibitor Type: VI
Literature (PubMed): <a href="https://pubchem.ncbi.nlm.nih.gov/compound/#section=Literature" target="_blank"> 0
Target(s): fibroblast growth factor receptor 2
Disease(s): cholangiocarcinoma

Futibatinib US FDA Label

Compound: 1-[(3S)-3-[4-amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]pyrazolo[3,4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one
Description: NA

International Nonproprietary Name: FUTIBATINIB [INN] (Source: PubChem)

SureChEMBL ID: SCHEMBL15345470 (Source: PubChem)

USFDA Precision ID: UNII-4B93MGE4AL (Source: PubChem)

US Adopted Name: Futibatinib [USAN] (Source: PubChem)

Sources: PubChem (4)